WBB Securities Co-Manages $25 Million Public Offering for TetraLogic
Posted: May 1st, 2015In: UncategorizedWBB Securities is acting as co-manager to a transaction for TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics in oncology.
Read More about WBB Securities Co-Manages $25 Million Public Offering for TetraLogic